Percutaneous ablation of pancreatic cancer

Pancreatic ductal adenocarcinoma is a highly aggressive tumor with an overall 5-year survival rate of less than 5%. Prognosis and treatment depend on whether the tumor is resectable or not, which mostly depends on how quickly the diagnosis is made. Chemotherapy and radiotherapy can be both used in c...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Onofrio, Mirko, Ciaravino, Valentina, De Robertis, Riccardo, Barbi, Emilio, Salvia, Roberto, Girelli, Roberto, Paiella, Salvatore, Gasparini, Camilla, Cardobi, Nicolò, Bassi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124972/
https://www.ncbi.nlm.nih.gov/pubmed/27956791
http://dx.doi.org/10.3748/wjg.v22.i44.9661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124972/
https://www.ncbi.nlm.nih.gov/pubmed/27956791
http://dx.doi.org/10.3748/wjg.v22.i44.9661

Ejemplares similares